Effect of Omalizumab (Xolair) on Basophils in Patients With Chronic Idiopathic Urticaria

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Genentech, Inc.
Information provided by (Responsible Party):
University of Colorado, Denver
ClinicalTrials.gov Identifier:
NCT01701583
First received: October 3, 2012
Last updated: June 18, 2015
Last verified: June 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: April 2017
  Estimated Primary Completion Date: April 2016 (Final data collection date for primary outcome measure)